BACKGROUND & AIMS: Although the incidence of hepatocellular carcinoma (HCC) is
increasing in the United States, data from large prospective studies are limited. We …

Methods HCV-positive patients with bridging fibrosis or cirrhosis that did not respond to
peginterferon and ribavirin were randomized to groups that were given maintenance …

Methods Hepatitis C virus-positive patients with bridging fibrosis or cirrhosis who did not
respond to peginterferon and ribavirin were randomized to groups that were given …

Although the incidence of hepatocellular carcinoma (HCC) is increasing in the United
States, data from large prospective studies are limited. We evaluated the Hepatitis C …

Background & Aims Although the incidence of hepatocellular carcinoma (HCC) is increasing
in the United States, data from large prospective studies are limited. We evaluated the …

Abstract Background and Aims—Although the incidence of hepatocellular carcinoma (HCC)
is increasing in the United States, data from large prospective studies are limited. We …

Background & Aims: Although the incidence of hepatocellular carcinoma (HCC) is
increasing in the United States, data from large prospective studies are limited. We …

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related
advanced liver disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Background & aims Although the incidence of hepatocellular carcinoma (HCC) is increasing
in the United States, data from large prospective studies are limited. We evaluated the …

Abstract Background and Aims—Although the incidence of hepatocellular carcinoma (HCC)
is increasing in the United States, data from large prospective studies are limited. We …